Roden RBS - Search Results

1

Chirality and asymmetry increase the potency of candidate ADRM1/RPN13 inhibitors.

Anchoori RK, George L, Tseng SH, Lam B, Polkampally S, Amiano AD, Foran P, Tsingine H, Samanapally H, Carrizo Velasquez F, Das S, Xing D, Bin Salam A, Karanam B, Hung CF, Roden RBS. Anchoori RK, et al. Among authors: roden rbs. PLoS One. 2021 Sep 10;16(9):e0256937. doi: 10.1371/journal.pone.0256937. eCollection 2021. PLoS One. 2021. PMID: 34506530 Free PMC article.

2

Enhancement of sindbis virus self-replicating RNA vaccine potency by targeting antigen to endosomal/lysosomal compartments.

Cheng WF, Hung CF, Hsu KF, Chai CY, He L, Ling M, Slater LA, Roden RB, Wu TC. Cheng WF, et al. Hum Gene Ther. 2001 Feb 10;12(3):235-52. doi: 10.1089/10430340150218387. Hum Gene Ther. 2001. PMID: 11177561

3

Cell surface-binding motifs of L2 that facilitate papillomavirus infection.

Yang R, Day PM, Yutzy WH 4th, Lin KY, Hung CF, Roden RB. Yang R, et al. J Virol. 2003 Mar;77(6):3531-41. doi: 10.1128/jvi.77.6.3531-3541.2003. J Virol. 2003. PMID: 12610128 Free PMC article.

4

Generation and characterization of DNA vaccines targeting the nucleocapsid protein of severe acute respiratory syndrome coronavirus.

Kim TW, Lee JH, Hung CF, Peng S, Roden R, Wang MC, Viscidi R, Tsai YC, He L, Chen PJ, Boyd DA, Wu TC. Kim TW, et al. J Virol. 2004 May;78(9):4638-45. doi: 10.1128/jvi.78.9.4638-4645.2004. J Virol. 2004. PMID: 15078946 Free PMC article.

5

Vaccines against human papillomavirus.

Lin YY, Alphs H, Hung CF, Roden RB, Wu TC. Lin YY, et al. Front Biosci. 2007 Jan 1;12:246-64. doi: 10.2741/2062. Front Biosci. 2007. PMID: 17127297 Review.

6

HLA-DQB1*02-restricted HPV-16 E7 peptide-specific CD4+ T-cell immune responses correlate with regression of HPV-16-associated high-grade squamous intraepithelial lesions.

Peng S, Trimble C, Wu L, Pardoll D, Roden R, Hung CF, Wu TC. Peng S, et al. Clin Cancer Res. 2007 Apr 15;13(8):2479-87. doi: 10.1158/1078-0432.CCR-06-2916. Clin Cancer Res. 2007. PMID: 17438108 Free PMC article.

7

Protection of rabbits against challenge with rabbit papillomaviruses by immunization with the N terminus of human papillomavirus type 16 minor capsid antigen L2.

Gambhira R, Jagu S, Karanam B, Gravitt PE, Culp TD, Christensen ND, Roden RB. Gambhira R, et al. J Virol. 2007 Nov;81(21):11585-92. doi: 10.1128/JVI.01577-07. Epub 2007 Aug 22. J Virol. 2007. PMID: 17715230 Free PMC article.

8

A protective and broadly cross-neutralizing epitope of human papillomavirus L2.

Gambhira R, Karanam B, Jagu S, Roberts JN, Buck CB, Bossis I, Alphs H, Culp T, Christensen ND, Roden RB. Gambhira R, et al. J Virol. 2007 Dec;81(24):13927-31. doi: 10.1128/JVI.00936-07. Epub 2007 Oct 10. J Virol. 2007. PMID: 17928339 Free PMC article.

9

Generation and characterization of a preventive and therapeutic HPV DNA vaccine.

Kim D, Gambhira R, Karanam B, Monie A, Hung CF, Roden R, Wu TC. Kim D, et al. Vaccine. 2008 Jan 17;26(3):351-60. doi: 10.1016/j.vaccine.2007.11.019. Epub 2007 Nov 29. Vaccine. 2008. PMID: 18096279 Free PMC article.

10

Antigen-specific immunotherapy of cervical and ovarian cancer.

Hung CF, Wu TC, Monie A, Roden R. Hung CF, et al. Immunol Rev. 2008 Apr;222:43-69. doi: 10.1111/j.1600-065X.2008.00622.x. Immunol Rev. 2008. PMID: 18363994 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

202 results

Search Page

Filters